Francesco Tedesco

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.

Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.

Journal: Frontiers in immunology

Published: May 12, 2026

Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.

Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.

Journal: Frontiers in immunology

Published: February 11, 2026

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti-Phospholipid Antibody-Associated Preterm Delivery.

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti-Phospholipid Antibody-Associated Preterm Delivery.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 02, 2026

Can we cure antiphospholipid syndrome?

Can we cure antiphospholipid syndrome?

Journal: Current opinion in immunology

Published: April 07, 2025

A novel multiobjective optimal LQ control strategy for energy harvesting in vehicle suspension systems.

A novel multiobjective optimal LQ control strategy for energy harvesting in vehicle suspension systems.

Journal: ISA transactions

Published: January 15, 2025

Mechanisms sensitive to different drugs mediate a proadhesive and pro-thrombotic platelet phenotype in antiphospholipid syndrome.

Mechanisms sensitive to different drugs mediate a proadhesive and pro-thrombotic platelet phenotype in antiphospholipid syndrome.

Journal: Haematologica

Published: December 10, 2024

β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model.

β2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model.

Journal: Frontiers in immunology

Published: October 31, 2024

Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy.

Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy.

Journal: Pediatric nephrology (Berlin, Germany)

Published: August 28, 2024

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

Journal: Rheumatology (Oxford, England)

Published: July 28, 2023

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.

Journal: Frontiers in immunology

Published: October 21, 2022

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.

Journal: Autoimmunity reviews

Published: October 07, 2022

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.

Journal: Haematologica

Published: June 08, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026